Zeemine 3mg Tablet

Introduction

Zeemine is a medication that contains the active ingredient Rivastigmine. It is available in tablet form and is commonly prescribed under the brand name Zeemine.

Uses

Zeemine is primarily used for the treatment of Alzheimer’s disease and Parkinson’s disease dementia. It helps to improve the symptoms associated with these conditions, such as memory loss, confusion, and difficulty with thinking and reasoning.

Dosage and Administration

The dosage of Zeemine may vary depending on the individual patient and the severity of their condition. Follow the instructions provided by your healthcare professional. Typically, the starting dose for Alzheimer’s disease is 1.5 mg twice daily, while for Parkinson’s disease dementia, the starting dose is 1.5 mg once daily. The dosage may be increased gradually as directed by your doctor.

Zeemine should be taken orally with water, usually with food to help reduce stomach upset. Swallow the tablet whole and not crush, chew, or divide it.

Mechanism of Action

The active ingredient in Zeemine, Rivastigmine, works by increasing the levels of a chemical called acetylcholine in the brain. Acetylcholine is involved in memory and other cognitive functions. By inhibiting the enzyme that breaks down acetylcholine, Rivastigmine helps to improve communication between nerve cells in the brain, which can improve cognitive function in patients with Alzheimer’s disease and Parkinson’s disease dementia.

Side Effects

Common side effects may include nausea, vomiting, diarrhea, loss of appetite, and weight loss. These side effects are usually mild and temporary. If they persist or become bothersome, consult your healthcare professional.

In some cases, Zeemine may cause more serious side effects, such as severe stomach pain, black or tarry stools, blood in the urine, or unusual bleeding or bruising. If you experience any of these symptoms, seek immediate medical attention.

Drug Interactions

Zeemine may interact with certain medications, including anticholinergic drugs, cholinesterase inhibitors, and nonsteroidal anti-inflammatory drugs (NSAIDs). Inform your healthcare professional about all the medications you are currently taking, including prescription medications, over-the-counter drugs, and herbal supplements, to avoid potential drug interactions.

Precautions

Before taking Zeemine, inform your healthcare professional about any allergies you may have, as well as any other medical conditions you have, including liver or kidney problems. Zeemine should be used with caution in patients with a history of stomach ulcers or seizures.

Avoid alcohol while taking Zeemine, as it may increase the risk of side effects.

Storage

Zeemine should be stored at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets. Do not use Zeemine if it has expired or if the packaging is damaged.

Patient Tips

• Take Zeemine exactly as prescribed by your healthcare professional. Do not take more or less than the recommended dose.
• If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• attend regular follow-up appointments with your healthcare professional to monitor your progress and adjust your treatment if necessary.
• If you experience any new or worsening symptoms while taking Zeemine, inform your healthcare professional.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Almuriva 13.3 mg/24 h transdermal patch (Health Professionals SmPC) Available at:
• Rivastigmine (Drugs.com) [Accessed 11 Jun. 2024] (online) Available at:
• rivastigmine (RX) [Accessed 12 Jun. 2024] (online) Available at:
• Rivastigmine (MedlinePlus) [Accessed 14 Jun. 2024] (online) Available at:
• Hansen RA, Gartlehner G, Webb AP, Morgan LC, Moore CG, Jonas DE. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: a systematic review and meta-analysis. Clin Interv Aging. 2008;3(2):211-25. [Accessed 15 Jun. 2024] Available at: